Review of toxicologic and radiologic risks to military personnel from exposure to depleted uranium during and after combat

Review of Toxicologic and Radiologic Risks to Military Personnel from Exposure to Depleted Uranium During and After Combat

Volumn , Issue , 2008, Pages 1-154

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85024119758     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/11979     Document Type: Book

References (265)

1. AEPI (U.S. Army Environmental Policy Institute). 1995. Health and Environmental Consequences of Depleted Uranium Use in the US Army. U.S. Army Environmental Policy Institute, Atlanta, GA [online]. Available: http://www.fas.org/man/dod-101/sys/land/docs/techreport.html [accessed July 9, 2007].
2. Archer, V.E., J.K. Wagoner, F.E. Lundin Jr. 1973. Cancer mortality among uranium mill workers. J. Occup. Med. 15(1):11-14.
3. Arfsten, D.P., M. Bekkedal, E.R. Wilfong, J. Rossi, III, K.A. Grasman, L.B. Healey, J.M. Rutkiewicz, E.W. Johnson, A.R. Thitoff, A.E. Jung, S.R. Lohrke, D.J. Schaeffer, K.R. Still. 2005. Study of the reproductive effects in rats surgically implanted with depleted uranium for up to 90 days. J. Toxicol. Environ. Health A 68(11-12):967-997.
4. Arfsten, D.P., D.J. Schaeffer, E.W. Johnson, R.J. Cunningham, K.R. Still, E.R. Wilfong. 2006. Evaluation of the effect of implanted depleted uranium on male reproductive success, sperm concentration, sperm velocity. Environ. Res. 100(2): 205-215.
5. Arfsten, D.P., E.R. Wilfong, M. Bekkedal, E.W. Johnson, S.M. McInurf, J.S. Egers, D.J. Schaeffer, K.R. Still. 2007. Evaluation of the effects of implanted depleted uranium (DU) pelletson adult rat behavior and toxicological endpoints. J. Toxicol. Environ. Health 70(23):1995-2010.
6. ATSDR (Agency for Toxic Substances and Disease Registry). 1999. Toxicological Profile for Uranium. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA [online]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp150.html [accessed July 9, 2007].
7. Autian, J., A.R. Singh, J.E. Turner, G.W. Hung, L.J. Nunez, W.H. Lawrence. 1975. Carcinogenesis from polyurethans. Cancer Res. 35(6):1591-1596.
8. Bailey, M., C. Marsh. 2001. Appendix 1. Exposures arising from the use of depleted uranium on the battlefield. Pp. 31-58 in The Health Hazards of Depleted Uranium Munitions, Part I. Policy Document 6/01. The Royal Society, London. May 22, 2001 [online]. Available: http://www.royalsoc.ac.uk/document.asp?tip=1&id= 1431 [accessed July 12, 2007].
9. Barber, D.S., M.F. Ehrich, B.S. Jortner. 2005. The effect of stress on the temporal and regional distribution of uranium in rat brain after acute uranyl acetate exposure. J. Toxicol. Environ. Health A 68(2):99-111.
10. Basset, S.H., A. Frenkel, N. Cedars, et al. 1948. The Excretion of Hexavalent Uranium Following Intravenous Administration. II. Studies on Human Subjects. USAEC report UR-37 (as cited in ATSDR 1999).
11. Beck, A.T., N. Epstein, G. Brown, R.A. Steer. 1988. An inventory for measuring clinical anxiety: psychometric properties. J. Consult Clin. Psychol. 56(6):893-897.
12. Beck, A.T., R.A. Steer, G.K. Brown. 1996. Manuel for the Beck Depression Inventory. San Antonio, TX: The Psychological Corporation.
13. Benson, K.A. 1998. Fetal development effects. Pp. 17-21 in Health Effects of Embedded Depleted Uranium Fragments, D.R. Livengood, ed. Report No. A987943. Special Publication 98-3. Bethesda, MD: Armed Forces Radiobiology Research Institute [online]. Available: http://www.afrri.usuhs.mil/www/outreach/reports/pdf/SP98-3.pdf [accessed July 12, 2007].
14. Benson, K.A., S.A. McBride. 1997. Uranium levels in the fetus and placenta of female rats implanted with depleted uranium pellets prior to breeding. Toxicologist 36(1 Pt. 2):258.
15. Beral, V., P. Fraser, L. Carpenter, M. Booth, A. Brown, G. Rose. 1988. Mortality of employees of the Atomic Weapons Establishment. Br. Med. J. 297(6651):757-770.
16. Berlin, M., B. Rudell. 1986. Uranium. Pp. 623-637 in Handbook on the Toxicology of Metals, Vol. II, 2nd Ed., L. Friberg, G. Nordberg, V. Vouk, eds. Amsterdam: Elsevier.
17. Bernard, S.R., E.G. Struxness. 1957. A Study of the Distribution and Excretion of Uranium in Man. ORNL-2304. Oak Ridge, TN: Oak Ridge National Laboratory.
18. BIPM (Bureau International des Poids et Mesures). 1998. Le systéme international d'unités (SI), 7th Ed. Sevres: Bureau International des Poids et Mesures.
19. Boback, M.W. 1975. A review of uranium excretion and clinical urinalysis data in accidental exposure cases. Pp. 225-243 in Conference Proceedings on Occupational Health Experience with Uranium, April 28-30, 1975, Arlington, VA. Document ERDA 93. Springfield VA: National Technical Information Service.
20. Boice, J.D., Jr., W.L. Bigbee, M.T. Mumma, W.J. Blot. 2003. Cancer mortality in counties near two former nuclear processing facilities in Pennsylvania, 1950-1995. Health Phys. 85(6):691-700.
21. Boice, J.D., Jr., W.L. Bigbee, M.T. Mumma, W.J. Blot. 2003. Cancer incidence in municipalities near two former nuclear materials processing facilities in Pennsylvania. Health Phys. 85(6):678-690.
22. Boice, J.D., Jr., M. Mumma, S. Schweitzer, W.J. Blot. 2003. Cancer mortality in a Texas county with prior uranium mining and milling activities, 1950-2001. J. Radiol. Protect. 23(3):247-262.
23. Bosque, M.A., J.L. Domingo, J. Corbella. 1992. Embryotoxicity of uranium in mice. Variability with the day of exposure. Rev. Toxicol. 97:107-110.
24. Bosque, M.A., J.L. Domingo, J.M. Llobet, J. Corbella. 1993. Embryotoxicity and teratogenicity of uranium in mice following subcutaneous administration of uranyl acetate. Biol. Trace Elem. Res. 36(2):109-118.
25. Brady, H.R., B.C. Kone, R.M. Brenner, S.R. Gullans. 1989. Early effects of uranyl nitrate on respiration and K+ transport in rabbit proximal tubule. Kidney Int. 36(1): 27-34.
26. Brand, K.G., K.H. Johnson, L.C. Buoen. 1976. Foreign body tumorigenesis. CRC Crit. Rev. Toxicol. 4(4):353-394.
27. BRH (U.S. Bureau of Radiological Health). 1970. Radiological Health Handbook, Rev. Ed. Publication No. 2016. Rockville, MD: U.S. Department of Health Education and Welfare, Public Health Service, Consumer Protection and Environmental Health Service. January 1970.
28. Brown, D.P., T. Bloom. 1987. Mortality Among Uranium Enrichment Workers. PB-87-188991/XAB. Cincinnati, OH: National Institute for Occupational Safety and Health.
29. Bussy, C., P. Lestaevel, B. Dhieux, C. Amourette, F. Paquet, P. Gourmelon, P. Houpert. 2006. Chronic ingestion of uranyl nitrate perturbs acetylcholinesterase activity and monoamine metabolism in male rat brains. Neurotoxicology 27(2):245-252.
30. Butterworth, A. 1955. Significance and value of uranium in urine analysis. Trans. Assoc. Ind. Med. Offrs 5:30-43 (as cited in ATSDR 1999).
31. Carpenter, L.M., C.D. Higgins, A.J. Douglas, N.E. Maconochie, R.Z. Omar, P. Fraser, V. Beral, P.G. Smith. 1998. Cancer mortality in relation to monitoring for radionuclide exposure in three UK nuclear industry workforces. Br. J. Cancer 78(9): 1224-1232.
32. Carroll, M.F., J.L. Tempte. 2000. Proteinuria in adults: a diagnostic approach. Am. Fam. Physician 62(6):1333-1340.
33. Checkoway, H, R.M. Mathew, J.L. Hickey, C.M. Shy, R.L. Harris, E.W. Hunt, G.T. Waldman. 1985. Mortality among workers in the Florida phosphate industry. I. Industry-wide cause-specific mortality patterns. J. Occup. Med. 27(12):885-892.
34. Checkoway, H., N. Pearce, D.J. Crawford-Brown, D.L. Cragle. 1988. Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am. J. Epidemiol. 127(2):255-266.
35. Checkoway, H., N.J. Heyer, P.A. Demers. 1996. An updated mortality follow-up study of Florida phosphate industry workers. Am. J. Ind. Med. 30(4):452-460.
36. Chen, J., D.P. Meyerhof, B.L. Tracy. 2004. Model results of kidney burdens from uranium intakes. Health Phys. 86(1):3-11.
37. Chevari, S., D. Likhner. 1968. Complex formation of natural uranium in blood [in Russian]. Med. Radiol. 13(8):53-57.
38. Conrad, K., J. Mehlhorn. 2000. Diagnostic and prognostic relevance of autoantibodies in uranium miners. Int. Arch. Allergy Immunol. 123(1):77-91.
39. Cookfair, D.L., W. Beck, C. Shy, C. Lushbaugh, C. Sowder. 1983. Lung cancer among workers at a uranium processing plant. Pp. 398-406 in Epidemiology Applied to Health Physics: Proceedings of the 16th Midyear Topical Meeting of the Health Physics Society, Jan. 9-13, 1983, Albuquerque, NM. Report DE83014383/ CONF-830101. Springfield, VA: National Technical Information Service, U.S. Department of Commerce.
40. Cooper, J.R., G.N. Stradling, H. Smith, S.E. Ham. 1982. The behaviour of uranium-233 oxide and uranyl-233 nitrate in rats. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 41(4):421-433.
41. Coryell, V.H., D.M. Stearns. 2006. Molecular analysis of hprt mutations generated in Chinese hamster ovary EM9 cells by uranyl acetate, by hydrogen peroxide and spontaneously. Mol. Carcinog. 45(1):60-72.
42. Craft, E.S., A. Abu-Qare, M. Flaherty, M. Garofolo, H. Rincavage, M. Abou-Donia. 2004. Depleted and natural uranium: Chemistry and toxicological effects. J. Toxicol. Environ. Health B Crit. Rev. 7(4):297-317.
43. Cragle, D.L., R.W. McLain, J.R. Qualters, J.L. Hickey, G.S. Wilkinson, W.G. Tankersley, C.C. Lushbaugh. 1988. Mortality among workers at a nuclear fuels production facility. Am. J. Ind. Med. 14(4):379-401.
44. Cross, F.T., R.F. Palmer, R.H. Busch, R.E. Filipy, B.O. Stuart. 1981. Development of lesions in Syrian golden hamsters following exposure to radon daughters and uranium ore dusts. Health Phys. 41(1):135-153.
45. Cross, F.T., R.E. Filipy, S.M. Loscutoff, P.J. Mihalko, R.F. Palmer, R.H. Busch. 1981. Histopathologic, Morphometric, Physiologic Investigation of Lungs of Dogs Exposed to Uranium-Ore Dust. PNL-SA-9927. Richland, WA: Battelle Pacific Northwest Labs.
46. de Rey, B.M., H.E. Lanfranchi, R.L. Cabrini. 1983. Percutaneous absorption of uranium compounds. Environ. Res. 30(2):480-491.
47. Derogatis, L.R. 1983. The Symptoms Checklist-90 Revised. Towson, MD: Clinical Psychometric Research.
48. Diamond, G.L., R.K. Zalups. 2005. Nephrotoxicology of uranium. Pp. 971-979 in Toxicology of the Kidney, 3rd Ed., J.B. Tarloff, L.H. Lash, eds. Boca Raton: CRC Press.
49. Diamond, G.L., P.E. Morrow, B.J. Panner, R.M. Gelein, R.B. Baggs. 1989. Reversible uranyl fluoride nephrotoxicity in the Long Evans rat. Fundam. Appl. Toxicol. 13(1):65-78.
50. Diaz Sylvester, P.L., R. López, A.M. Ubios, R.L. Cabrini. 2002. Exposure to subcutaneously implanted uranium dioxide impairs bone formation. Arch. Environ. Health 57(4):320-325.
51. DOD (U.S. Department of Defense). 2001. Information Paper: Depleted Uranium Environmental and Medical Surveillance in the Balkans [online]. Available: http://fhp.osd.mil/du/du_balkans/ [accessed July 6, 2007].
52. DOE (U.S. Department of Energy). 2004. Environmental Monitoring Results, Annual Site Environmental Report for Calendar Year 2003, Paducah Gaseous Diffusion Plant, Paducah, Kentucky., Vol. II. BJC/PAD-611/V2. Prepared by CDM Federal Services Inc., for Office of Environmental Management, U.S. Department of Energy [online]. Available: http://www.prs-llc.net/aser/2003%20ASER/2003%20 ASER%20Data%20Volume.pdf [accessed July 9, 2007].
53. Domingo, J.L. 2001. Reproductive and developmental toxicity of natural and depleted uranium: A review. Reprod. Toxicol. 15(6):603-609.
54. Domingo, J.L., J.M. Llobet, J.M. Tomás, J. Corbella. 1987. Acute toxicity of uranium in rats and mice. Bull. Environ. Contam. Toxicol. 39(1):168-174.
55. Domingo, J.L., A. Ortega, J.L. Paternain, J. Corbella. 1989. Evaluation of the perinatal and postnatal effects of uranium in mice upon oral administration. Arch. Environ. Health 44(6):395-398.
56. Dublineau, I., S. Grison, C. Linard, C. Baudelin, N. Dudoignon, M. Souidi, C. Marquette, F. Paquet, J. Aigueperse, P. Gourmelon. 2006. Short-term effects of depleted uranium on immune status in rat intestine. J. Toxicol. Environ. Health A 69(17): 1613-1628.
57. Dupree, E.A., D.L. Cragle, R.W. McLain, D.J. Crawford-Brown, M.J. Teta. 1987. Mortality among workers at a uranium processing facility, the Linde Air Products Company Ceramics Plant, 1943-1949. Scand. J. Work Environ. Health. 13(2):100-107.
58. Dupree, E.A., J.P. Watkins, J.N. Ingle, P.W. Wallace, C.M. West, W.G. Tankersley. 1995. Uranium dust exposure and lung cancer risk in four uranium processing operations. Epidemiology 6(4):370-375.
59. Dupree-Ellis, E., J. Watkins, J.N. Ingle, J. Phillips. 2000. External radiation exposure and mortality in a cohort of uranium processing workers. Am. J. Epidemiol. 152(1):91-95.
60. Durbin, P.W. 1984. Metabolic models for uranium. Pp. F1-F65 in Biokinetics and Analysis of Uranium in Man, R.H. Moore, ed. Report USUR-05, HEHF-47 Richland, WA: U. S. Uranium Registry and Joint Center for Graduate Study.
61. Dygert, H.R., C.W. LaBelle, S. Laskin, U.C. Pozzani, E. Roberts, J.J. Rothermel, A. Rothstein, C.J. Spiegel, G.F. Sprague, Jr., H.E. Stokinger. 1949. Toxicity following inhalation. Pp. 423-700 in Pharmacology and Toxicology of Uranium Compounds, C. Voegtlin, H.C. Hodge, eds. New York: McGraw-Hill.
62. Eisenbud, M., T.F. Gesell. 1997. Environmental Radioactivity, 4th Ed. San Diego: Academic Press.
63. EPA (U.S. Environmental Protection Agency). 1991. Risk Assessment Guidance for Superfund Volume 1: Human Health Evaluation Manual Supplemental Guidance: Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.PB91-921314. Office of Solid Waste and Emergency Response, U.S. Environmental Protection Agency, Washington, DC. March 25, 1991 [online]. Available: http://www.epa.gov/oswer/riskassessment/pdf/oswer_directive_9285_6-03.pdf [accessed July16, 2007].
64. EPA (U.S. Environmental Protection Agency). 1999. Cancer Risk Coefficients for Environmental Exposure to Radionuclides. EPA 402-R-99-001. Federal Guidance Technical Report No. 13. Office of Air and Radiation, U.S. Environmental Protection Agency [online]. Available: http://www.epa.gov/radiation/docs/federal/402-r-99-001.pdf [accessed July 13, 2007].
65. FAS (Federation of American Scientists). 2000. GAU-8 Avenger. Aircraft Equipment. Military Analysis Network [online]. Available: http://www.fas.org/man/dod-101/ sys/ac/equip/gau-8.htm [accessed June 19, 2006].
66. Faure, G., T.M. Mensing. 2005. Isotopes: Principles and Applications, 3rd Ed. Hoboken, NJ: Wiley.
67. Fetter, S., F.N. von Hippel. 1999. The hazard posed by depleted uranium munitions. Sci. Global Secur. 8(2):125-161.
68. Filippova, L.G., A.P. Nifatov, E.R. Liubchanskii. 1978. Late sequelae of administering enriched uranium to rats [in Russian]. Radiobiologiia 18(3):400-405.
69. Firestone, R.B., V.S. Shirley. 1996. Table of Isotopes, 8th Ed., Vol. 2. New York: John Wiley and Sons.
70. Fisenne, I.M., G.A. Welford. 1986. Natural U concentration in soft tissues and bone of New York City residents. Health Phys. 50(6):739-746.
71. Fisher, D.R., M.J. Swint, R.L. Kathren. 1990. Evaluation of Health Effects in Sequoyah Fuels Corporation Workers from Accidental Exposure to Uranium Hexafluoride. NUREG/CR-5566. PNL 7328. Washington DC: U.S. Nuclear Regulatory Commission.
72. Fisher, D.R., R.L. Kathren, M.J. Swint. 1991. Modified biokinetic model for uranium from analysis of acute exposure to UF6. Health Phys. 60(3):335-342.
73. Gilchrist, R.L., P.W. Nickola, J.A. Glissmeyer, J. Mishima. 1999. Characterization of Airborne Depleted Uranium From April 1978 Test Firing of the 105-mm, APFSDS-T, M735E1 Cartridge. Report PNL-2881. Richland, WA: Battelle Pacific Northwest National Laboratory. June 1999.
74. Gilman, A.P., D.C. Villeneuve, V.E. Secours, A.P. Yagminas, B.L. Tracy, J.M. Quinn, V.E. Valli, R.J. Willes, M.A. Moss.1998a. Uranyl nitrate: 28-day and 91-day toxicity studies in the Sprague-Dawley rat. Toxicol. Sci. 41(1):117-128.
75. Gilman, A.P., D.C. Villeneuve, V.E. Secours, A.P. Yagminas, B.L. Tracy, J.M. Quinn, V.E. Valli, M.A. Moss. 1998b Uranyl nitrate: 91-day toxicity studies in the New Zealand white rabbit. Toxicol. Sci. 41(1):129-137.
76. Gilman, A.P., M.A. Moss, D.C. Villeneuve, V.E. Secours, A.P. Yagaminas, B.L. Tracy, J.M. Quinn, G. Long, V.E. Valli. 1998. Uranyl nitrate: 91-day exposure and recovery studies in the male New Zealand white rabbit. Toxicol. Sci. 41(1):138-151.
77. Glissmeyer, J.A., J. Mishima. 1979. Characterization of Airborne Uranium from Test Firings of XM774 Ammunition. Report PNL-2944. Richland, WA: Pacific North west Laboratory [online]. Available: http://www.mindfully.org/Nucs/Airborne-Uranium-Glissmeyer1nov79.htm [accessed July 16, 2007].
78. Goldman, M., A. Yaari, Z. Doshnitzki, R. Cohen-Luria, A. Moran. 2006. Nephrotoxicity of uranyl acetate: Effect on rat kidney brush border membrane vesicles. Arch. Toxicol. 80(7):387-393.
79. Gray, G.C., B.D. Coate, C.M. Anderson, H.K. Kang, S.W. Berg, F.S. Wignall, J.D. Knoke, E. Barrett-Conner. 1996. The postwar hospitalization experience of U.S. veterans of the Persian Gulf War. N. Engl. J. Med. 335(10):1505-1513.
80. Greaves, P., J.M. Martin, Y. Rabemampianina. 1985. Malignant fibrous histiocytoma in rats at sites of implanted millipore filters. Am. J. Pathol. 120(2):207-214.
81. Guilmette, R.A., M.A. Parkhurst, G. Miller, E.F. Hahn, L.E. Roszell, E.G. Daxon, T.T. Little, J.J. Whicker, Y.S. Cheng, R.J. Traub, G.M. Lodde, F. Szrom, D.E. Bihl, K.L. Creek, C.B. McKee. 2005. Human Health Risk Assessment of Capstone Depleted Uranium Aerosols. Attachment 3 of Depleted Uranium Aerosol Doses and Risks: Summary of U.S. Assessments. Columbus, Ohio: Battelle Press.
82. Hadjimichael, O.C., A.M. Ostfeld, D.A. D'Atri, R.E. Brubaker. 1983. Mortality and cancer incidence experience of employees in a nuclear fuels fabrication plant. J. Occup. Med. 25(1):48-61.
83. Hahn, F.F., R.A. Guilmette, M.D. Hoover. 2002. Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats. Environ. Health Perspect. 110(1):51-59.
84. Hamilton, E.I. 1970. Uranium content of normal blood. Nature 227(Aug. 1):501-502.
85. Hamilton, M.M., J.W. Ejnik, A.J. Carmichael. 1997. Uranium reactions with hydrogen peroxide studies by EPR-spin trapping with DMPO. Perkin Trans. 2(12): 2491-2494.
86. Harduin, J.C., P. Royer, J. Piechowski. 1994. Uptake and urinary excretion of uranium after oral administration in man. Radiat. Prot. Dosim. 53:245-248.
87. Harley, N.H., E.C. Foulkes, L.H. Hilborne, A. Hudson, C.R. Anthony. 1999. A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol. 7. Depleted Uranium. RAND's National Defense Research Institute, Santa Monica, CA [online]. Available: http://www.rand.org/pubs/monograph_reports/2005/MR 1018.7.pdf [accessed July 9, 2007].
88. Harris, W.B. 1961. Experimental clearance of uranium dust from the human body. Pp. 209-220 in Inhaled Particles and Vapours, Vol. 1, C.N. Davies, ed. London: Pergamon Press.
89. Hartsock, W.J., J.D. Cohen, D.J. Segal. 2007. Uranyl acetate as a direct inhibitor of DNA-binding proteins. Chem. Res. Toxicol. 20(5):784-789.
90. Healy, J.W. 1970. Los Alamos Handbook of Radiation Monitoring. Technical Report LA-4400. Los Alamos Scientific Laboratory, NM.
91. Hedaya, M.A., H.P. Birkenfeld, R.L. Kathren. 1997. A sensitive method for the determination of uranium in biological samples utilizing kinetic phosphorescence analysis (KPA). J. Pharm. Biomed. Anal. 15(8):1157-1165.
92. Hooper, F.J., K.S. Squibb, E.L. Siegel, K. McPhaul, J.P. Keogh. 1999. Elevated urine uranium excretion by soldiers with retained uranium shrapnel. Health Phys. 77(5): 512-519.
93. Houpert, P., P. Lestaevel, C. Bussy, F. Paquet, P. Gourmelon. 2005. Enriched but not depleted uranium affects central nervous system in long term exposed rats. Neurotoxicology 26(6):1015-1020.
94. HPS (Health Physics Society). 1995. Risk Assessment: Position Statement of the Health Physics Society. PS008-1. Health Physics Society [online]. Available: http://hps. org/documents/riskassessment_ps008-1.pdf [accessed July 16, 2007].
95. Hueper, W.C., J.H. Zuefle, A.M. Link, M.G. Johnson. 1952. Experimental studies in metal cancerigenesis. II. Experimental uranium cancers in rats. J. Natl. Cancer Inst. 13(2):291-305.
96. Hursh, J.B., W.R. Neuman, T. Toribara, H. Wilson, C. Waterhouse. 1969. Oral ingestion of uranium by man. Health Phys. 17(4):619-621.
97. IARC (International Agency for Resarch on Cancer). 1999. Surgical Implants and Other Foreign Bodies, Volume 74. Lyon, France: IARC.
98. ICRP (International Commission on Radiological Protection). 1975. Report of the Task Group on Reference Man. ICRP No. 23. Oxford: Pergamon Press.
99. ICRP (International Commission on Radiological Protection). 1977. Recommendations of the International Commission on Radiological Protection: Adapted January 17, 1977. ICRP No. 26. Annals of the ICRP 1(3). Oxford: Pergamon Press.
100. ICRP (International Commission on Radiological Protection). 1979. Limits for Intakes of Radionuclides by Workers. ICRP No. 30, Part 1. Annals of the ICRP 2(3/4). Oxford: Pergamon Press.
101. ICRP (International Commission on Radiological Protection). 1983. Radionuclide Transformations: Energy and Intensity of Emissions: Radiation Protection. ICRP No. 38. Annals of the ICRP 11-13. Oxford: Pergamon Press.
102. ICRP (International Commission on Radiological Protection). 1988. Individual Monitoring for Intakes of Radionuclides by Workers: Design and Interpretation. ICRP No. 54. Annals of the ICRP 19(1/3). Oxford: Pergamon Press.
103. ICRP (International Commission on Radiological Protection). 1991. 1990 Recommendations of the International Commission on Radiological Protection. ICRP No. 60. Annals of the ICRP 21(1-3). Oxford: Pergamon Press.
104. ICRP (International Commission on Radiological Protection). 1994. Human Respiratory Tract Model for Radiological Protection: A Report of a Task Group of the International Commission on Radiological Protection, 1st Ed. ICRP No. 66 Annals of the ICRP 24(1-3). Oxford: Pergamon Press.
105. ICRP (International Commission on Radiological Protection). 1994. Dose Coefficients for Intakes of Radionuclides by Workers. ICRP No. 68. Annals of the ICRP 24(4). Oxford: Pergamon Press.
106. ICPR (International Commission on Radiological Protection). 1995. Age-Dependent Dose to Members of the Public from Intake of Radionuclides: Part 3. Ingestion Dose Coefficients. ICRP No. 69. Annals of the ICRP 25(1). Oxford: Pergamon Press.
107. ICRP (International Commission on Radiological Protection). 1995. Age-Dependent Doses to Members of the Public from Intake of Radionuclides: Part 4. Inhalation Dose Coefficients, 1st Ed. ICRP No. 71. Annals of the ICRP 25(1-3). Oxford: Pergamon Press.
108. ICRP (International Commission on Radiological Protection). 1996. Age-Dependent Dose to Members of the Public from Intake of Radionuclides: Part 5. Compilation of Ingestion and Inhalation Dose Coefficients. ICRP No. 72. Annals of the ICRP 26(1). Oxford: Pergamon Press.
109. ICRP (International Commission on Radiological Protection). 1997. Individual Monitoring for Internal Exposure of Workers. ICRP No. 78. Annals of the ICRP 27(3-4). Oxford: Pergamon Press.
110. IOM (Institute of Medicine). 2000. Depleted uranium. Pp. 89-168 in Gulf War and Health: Volume 1. Depleted Uranium, Pyridostigmine Bromide, Sarin, Vaccines, C.E. Fulco, C.T. Liverman, H.C. Sox, eds. Washington, DC: National Academy Press.
111. Izgüt-Uysal, V.N., N. Derin, A. Agaç. 2000. Effect of cold-restraint stress on the distribution of trace elements in rat brain. Biol. Trace Elem. Res. 78(1-3):149-155.
112. Jastak, S., G. Wilkinson. 1993. Wide Range Achievement Test, 3rd Ed. Wilmington, DE: Wide Range, Inc.
113. Jette, S.J., J. Mishima, D.E. Hadlock. 1990. Aerosolization of the M829A1 and XM900E1 Rounds Fired Against Hard Targets. Report PNL-7452. Richland, WA: Battelle Pacific Northwest Laboratory. August 1990.
114. Kalinich, J., N. Ramakrishnan, D. McClain. 1998. Depleted uranium-induced immunotoxicity. Pp. 15-16 in Health Effects of Embedded Depleted Uranium Fragments, D.R. Livengood, ed. Report No. A987943. Special Publication 98-3. Bethesda, MD: Armed Forces Radiobiology Research Institute [online]. Available: http://www.afrri.usuhs.mil/www/outreach/reports/pdf/SP98-3.pdf [accessed July 12, 2007].
115. Kalinich, J., N. Ramakrishnan, V. Villa, D.E. McClain. 2002. Depleted uraniumuranyl chloride induces apoptosis in mouse J774 macrophages. Toxicology 179(1-2):105-114.
116. Kane, R.L., D.L. Reeves. 1997. Computerized test batteries. Pp. 423-462 in The Neuropsychology Handbook, Vol. 1. Foundations and Assessment, A. Horton, D. Wedding, eds. New York: Springer.
117. Kashif, W., N. Siddiqi, A.P. Dincer, H.E. Dincer, S. Hirsch. 2003. Proteinuria: How to evaluate an important finding. Cleve. Clin. J. Med. 70(6):535-547.
118. Kathren, R.L. 1975. Standard sources for health physics instrument calibration. Health Phys. 29(1):143-152.
119. Kathren, R.L. 1997. Uranium in the tissues of two whole body donations to the USTUR. Pp. 59-75 in U.S. Transuranium and Uranium Registries Annual Report October 1, 1995-September 30, 1996. USTUR-0072-97. Richland, WA: Washington State University.
120. Kathren, R.L. 2001. Ionizing radiation quantities and units. Chapter 2 in Radiation Instruments, H. Cember, ed. Madison: Medical Physics Pub.
121. Kathren, R.L., R.H. Moore. 1986. Acute accidental inhalation of U: A 38 year follow-up. Health Phys. 51(5):609-619.
122. Keane, T.M., J.M. Caddell, K.L. Taylor. 1988. Mississippi Scale for combat-related post-traumatic stress disorder: Three studies in reliability and validity. J. Consult. Clin. Psychol. 56(1): 85-90.
123. Kennedy, W.E., Jr., D.L. Strenge. 1992. Residual Radioactive Contamination from Decommissioning: Technical Basis for Translating Contamination Levels to Annual Total Effective Dose Equivalent. NUREG/CR-5512-Vol. 1. PNL-7994-Vol. 1. Washington, DC: U.S. Nuclear Regulatory Commission.
124. Kinsman, S. 1954. Radiological Health Handbook. Cincinnati, OH: Radiological Health Training Section, Sanitary Engineering Center.
125. Knief, R.A. 1992. Nuclear Engineering: Theory and Technology of Commercial Nuclear Power. Washington, DC: Hemisphere Publishing Corporation.
126. Knöbel, Y., M. Glei, A. Weise, K. Osswald, A. Schaferhenrich, K.K. Richter, U. Claussen, B.L. Pool-Zobel. 2006. Uranyl nitrilotriacetate, a stabilized salt of uranium, is genotoxic in nontransformed human colon cells and in the human colon adenoma cell line LT97. Toxicol. Sci. 93(2):286-297.
127. Knoke, J.D., G.C. Gray, F.C. Garland. 1998. Testicular cancer and Persian Gulf War service. Epidemiology 9(6):648-653.
128. Koshurnikova, N.A., M.G. Bolotnikova, L.A. Ilyin, I.B. Keirim-Markus, Z.S. Menshikh, P.V. Okatenko, S.A. Romanov, V.I. Tsvetkov, N.S. Shilnikova. 1998. Lung cancer risk due to exposure to incorporated plutonium. Radiat. Res. 149(4):366-371.
129. Kurttio, P., A. Auvinen, L. Salonen, H. Saha, J. Pekkanen, I. Makelainen, S.B. Vaisanen, I.M. Penttila, H. Komulainen. 2002. Renal effects of uranium in drinking water. Environ. Health Perspect. 110(4):337-342.
130. Kurttio, P., H. Komulainen, A. Leino, L. Salonen, A. Auvinen, H. Saha. 2005. Bone as a possible target of chemical toxicity of natural uranium in drinking water. Environ. Health Perspect. 113(1):68-72.
131. Kurttio, P., A. Harmoinen, H. Saha, L. Salonen, Z. Karpas, H. Komulainen, A. Auvinen. 2006. Kidney toxicity of ingested uranium from drinking water. Am. J. Kidney Dis. 47(6):972-982.
132. L'Azou, B., M.H. Henge-Napoli, L. Minaro, H. Mitro, M.P. Barrouillet, J. Cambar. 2002. Effects of cadmium and uranium on some in vitro renal targets. Cell Biol. Toxicol. 18(5):329-340.
133. Leach, L.J., E.A. Maynard, H.C. Hodge, J.K. Scott, C.L. Yuile, G.E. Sylvester, H.B. Wilson. 1970. A five-year inhalation study with natural uranium dioxide (UO2) dust. I. Retention and biologic effect in the monkey, dog and rat. Health Phys. 18(6):599-612.
134. Leach, L.J., C.L. Yuile, H.C. Hodge, G.E. Sylvester, H.B. Wilson. 1973. A five-year inhalation study with natural uranium dioxide (UO2) dust-II. Post exposure retention and biological effects in monkey, dog and rat. Health Phys. 25(3):239-258.
135. Leach, L.J., R.M. Gelein, B.J. Panner, C.L. Yulie, C.C. Cox. 1984. The Acute Toxicity of the Hydrolysis Products of Uranium Hexafluoride (UF6) When Inhaled by the Rat and Guinea Pig. Final report. NTIS/DE 84011539. Rochester University, New York.
136. Leggett, R.W. 1989. The behavior and chemical toxicity of U in the kidney: A reassessment. Health Phys. 57(3):365-383.
137. Leggett, R.W. 1992. A generic age-specific biokinetic model for calcium-like elements. Radiat. Prot. Dosim. 41(2):183-198.
138. Leggett, R.W., J.D. Harrison. 1995. Fractional absorption of ingested uranium in humans. Health Phys. 68(4):484-498.
139. Leggett, R.W., T.C. Pellmar. 2003. The biokinetics of uranium migrating from embedded DU fragments. J. Environ. Radioact. 64(2-3):205-225.
140. Lemercier, V., X. Millot, E. Ansoborlo, F. Ménétrier, A. Flüry-Hérard, C. Rousselle, J.M. Scherrmann. 2003. Study of uranium transfer across the blood-brain barrier. Radiat. Prot. Dosimetry 105(1-4):243-245.
141. Lestaevel, P., P. Houpert, C. Bussy, B. Dhieux, P. Gourmelon, F. Paquet. 2005. The brain is a target organ after acute exposure to depleted uranium. Toxicology 212(2-3):219-226.
142. Lin, R.H., L.J. Wu, C.H. Lee, S.Y. Lin-Shiau. 1993. Cytogenetic toxicity of uranyl nitrate in Chinese hamster ovary cells. Mutat. Res. 319(3):197-203.
143. Lipsztein, J.L. 1981. An Improved Model for Uranium Metabolism in the Primate. Ph.D. Thesis, New York University Institute of Environmental Medicine, New York.
144. Llobet, J.M., J.J. Sirvent, A. Ortega, J.L. Domingo. 1991. Influence of chronic exposure to uranium on male reproduction in mice. Fundam. Appl. Toxicol. 16(4):821-829.
145. Lloyd, D.C., J.N. Lucas, A.A. Edwards, W. Deng, E. Valente, P.A. Hone, J.E. Moquet. 2001. A study to verify a reported excess of chromosomal aberrations in blood lymphocytes of Namibian uranium miners. Radiat. Res. 155(6):809-817.
146. Loomis, D.P., S.H. Wolf. 1996. Mortality of workers at a nuclear materials production plant at Oak Ridge, Tennessee, 1947-1990. Am. J. Ind. Med. 29(2):131-141.
147. Lopez, R., P.L. Diaz Sylvester, A.M. Ubios, R.L. Cabrini. 2000. Percutaneous toxicity of uranyl nitrate: Its effect in terms of exposure area and time. Health Phys. 78 (4):434-437.
148. Lopez-Abente, G., N. Aragones, M. Pollan, M. Ruiz, A. Gandarillas. 1999. Leukemia, lymphomas, myeloma mortality in the vicinity of nuclear power plants and nuclear fuel facilities in Spain. Cancer Epidemiol. Biomarkers Prev. 8(10): 925-934.
149. Lopez-Abente, G., N. Aragones, M. Pollan. 2001. Solid-tumor mortality in the vicinity of uranium cycle facilities and nuclear power plants in Spain. Environ. Health Perspect. 109(7):721-729.
150. Luessenhop, A.J., J.C. Gallimore, W.H. Sweet, E.G. Struxness, J. Robinson. 1958. The toxicity in man of hexavalent uranium following intravenous administration. Am. J. Roentgenol. Radium. Ther. Nucl. Med. 79(1):83-100.
151. Macfarlane, G.J., A.M. Biggs, N. Maconochie, M. Hotopf, P. Doyle, M.Lunt. 2003. Incidence of cancer among UK Gulf war veterans: Cohort study. Br. Med. J. 327(7428):1373-1377.
152. Marshall, A.C. 2005. An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study. SAND 2005-4331. Sandia National Laboratories, Albuquerque, NM and Livermore, CA [online]. Available: http://www.sandia.gov/news-center/ news-releases/2005/all/snl-dusand.pdf [accessed July 6, 2007].
153. Martin, R., R. Earl, E.J. Tawn. 1991. A cytogenetic study of men occupationally exposed to uranium. Br. J. Ind. Med. 48(2):98-102.
154. Mason, T.J., J.F. Fraumeni, F.W. McKay. 1972. Uranium mill tailings and cancer mortality in Colorado. J. Natl. Cancer Inst. 49(3):661-664.
155. Maynard, E.A., H.C. Hodge. 1949. Studies of the toxicity of various uranium compounds when fed to experimental animals. Pp. 309-376 in Pharmacology and Toxicology of Uranium Compounds, C. Voegtlin, H.C. Hodge, eds. New York: McGraw-Hill.
156. Maynard, E.A., W.L. Downs, H.C. Hodge. 1953. Oral toxicity of uranium compounds. Pp. 1221-1369 in Pharmacology and Toxicology of Uranium Compounds, Vol. III, C. Voegtlin, H.C. Hodge, eds. New York: McGraw-Hill.
157. McDiarmid, M.A. 2001. Depleted uranium and public health. Br. Med. J. 322(7279):123-124.
158. McDiarmid, M.A., J.P. Keogh, F.J. Hooper, K. McPhaul, K. Squibb, R. Kane, R. DiPino, M. Kabat, B. Kaup, L. Anderson, D. Hoover, L. Brown, M. Hamilton, D. Jacobson-Kram, B. Burrows, M. Walsh. 2000. Health effects of depleted uranium on exposed Gulf War veterans. Environ. Res. 82(2):168-180.
159. McDiarmid, M.A., S.M. Englehardt, M. Oliver. 2001. Urinary uranium concentrations in an enlarged Gulf War veteran cohort. Health Phys. 80(3):270-273.
160. McDiarmid, M.A., K.S. Squibb, S. Engelhardt, M. Oliver, P. Gucer, P.D. Wilson, R. Kane, M. Kabat, B. Kaup, L. Anderson, D. Hoover, L. Brown, D. Jacobson-Kram. 2001. Surveillance of depleted uranium exposed Gulf War veterans: Health effects observed in an enlarged friendly fire cohort. J. Occup. Environ. Med. 43(12):991-1000.
161. McDiarmid, M.A., K. Squibb, S.M. Engelhardt. 2004. Biologic monitoring for urinary uranium in Gulf War I veterans. Health Phys. 87(1):51-56.
162. McDiarmid, M.A., S. Engelhardt, M. Oliver, P. Gucer, P.D. Wilson, R. Kane, M. Kabat, B. Kaup, L. Anderson, D. Hoover, L. Brown, B. Handwerger, R.J. Albertini, D. Jacobson-Kram, C.D. Thorne, K.S. Squibb. 2004. Health effects of depleted uranium on exposed Gulf War veterans: A 10-year follow-up. J. Toxicol. Environ. Health A 67(4):277-296.
163. McDiarmid, M.A., S.M. Englehardt, M. Oliver, P. Guccer, P.D. Wilson, R. Kane, M. Kabat, B. Kaup, L. Anderson, D. Hoover, L. Brown, R.J. Albertini, R. Gudi, D. Jacobson-Kram, C.D. Thorne, K.S. Squibb. 2006. Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium. Int. Arch. Occup. Health 79(1):11-21.
164. McDiarmid, M.A., S.M. Englehardt, M. Oliver, P. Gucer, P.D. Wilson, R. Kane, A. Cernich, B. Kaup, L. Anderson, D. Hoover, L. Brown, R. Albertini, R. Gudi, D. Jacobson-Kram, K.S. Squibb. 2007. Health surveillance of Gulf War veterans exposed to depleted uranium: Updating the cohort. Health Phys. 93(1):60-73.
165. McDonald-Taylor, C.K, M.K. Bhatnagar, A. Gilman, A. Yagminas, A. Singh. 1992. Uranyl nitrate-induced glomerular basement membrane alterations in rabbits: A quantitative analysis. Bull. Environ. Contam. Toxicol. 48(3):367-373.
166. McGeoghegan, D., K. Binks. 2000. Mortality and cancer morbidity experience of workers at Springfields uranium production facility, 1946-1995. J. Radiol. Prot. 20(2):111-137.
167. McGeoghegan, D., K. Binks. 2000. The mortality and cancer morbidity experience of workers at the Capenhurst uranium enrichment facility 1946-95. J. Radiol. Protect. 20(4):381-401.
168. McGregor, D.B., R.A. Baan, C. Partensky, J.M. Rice, J.D. Wilbourn. 2000. Evaluation of the carcinogenic risks to humans associated with surgical implants and other foreign bodies-a report of an IARC Monographs Programme Meeting, International Agency for Research on Cancer. Eur. J. Cancer 36(3):307-313.
169. Medley, D.W., R.L. Kathren, A.G. Miller. 1994. Diurnal urinary volume and uranium output in uranium workers and unexposed controls. Health Phys. 67(2):122-130.
170. Meshorer, E., C. Erb, R. Gazit, L. Pavlovsky, D. Kaufer, A. Friedman, D. Glick, N. Ben-Arie, H. Soreq. 2002. Alternative splicing and neuritic mRNA translocation under long term neuronal hypersensitivity. Science 295(5554):508-513.
171. Miller, A.C., W.F. Blakely, D. Livengood, T. Whittaker, J. Xu, J.W. Ejnik, M.M. Hamilton, E. Parlette, T. St. John, H.M. Gerstenberg, H. Hsu. 1998. Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uraniumuranyl chloride. Environ. Health. Perspect. 106(8):465-471.
172. Miller, A.C., A.F. Fuciarelli, W.E. Jackson, E.J. Ejnik, C. Emond, S. Strocko, J. Hogan, N. Page, T. Pellmar. 1998. Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets. Mutagenesis 13(6):643-648.
173. Miller, A.C., J. Xu, M. Stewart, K. Brooks, S. Hodge, L. Shi, N. Page, D. McClain. 2002. Observation of radiation - specific damage in human cells exposed to depleted uranium: Dicentric frequency and neoplastic transformation as endpoints. Radiat. Prot. Dosimetry 99(1-4):275-278.
174. Miller, A.C., M. Stewart, K. Brooks, L. Shi, N. Page. 2002. Depleted uraniumcatalyzed oxidative DNA damage: Absence of significant alpha particle decay. J. Inorg. Biochem. 91(1):246-252.
175. Miller, A.C., K. Brooks, M. Stewart, B. Anderson, L. Shi, D. McClain, N. Page. 2003. Genomic instability in human osteoblast cells after exposure to depleted uranium: Delayed lethality and micronuclei formation. J. Environ. Radioact. 64(2-3):247-259.
176. Mirto, H., M.P. Barrouillet, M.H. Henge-Napoli, E. Ansoborio, M. Fournier, J. Cambar. 1999. Uranium-induced vasoreactivity in isolated glomeruli and cultured rat mesangial cells. Toxicol. In Vitro 13(4):707-711.
177. Mitchel, R.E., S. Sunder. 2004. Depleted uranium dust from fired munitions: Physical, chemical and biological properties. Health Phys. 87(1):57-67.
178. Mitchel, R.E., J.S. Jackson, B. Heinmiller. 1999. Inhaled uranium ore dust and lung cancer risk in rats. Health Phys. 76(2):145-155.
179. Mitchell, S.E., C.A. Caldwell, G. Gonzales, W.R. Gould, R. Arimoto. 2005. Effects of depleted uranium on survival, growth and metamorphosis in the African clawed frog (Xenopus laevis). J. Toxicol. Environ. Health 68(11-12):951-965.
180. Monleau, M., C. Bussy, P. Lestaevel, P. Houpert, F. Paquet, V. Chazel. 2005. Bioaccumulation and behavioral effects of depleted uranium in rats exposed to repeated inhalations. Neurosci. Lett. 390(1):31-36.
181. Monleau, M., M. De Meo, F. Paquet, V. Chazel, G. Dumenil, M. Donnadieu-Claraz. 2006. Genotoxic and inflammatory effects of depleted uranium particles inhaled by rats. Toxicol. Sci. 89(1):287-295.
182. Morris, K.J., P. Khanna, A.L. Batchelor. 1990. Long-term clearance of inhaled UO2 particles from the pulmonary region of the rat. Health Phys. 58(4):477-485.
183. Morrow, P.E., F.R. Gibb, H.D. Beiter. 1972. Inhalation studies of uranium trioxide. Health Phys. 23(3):273-280.
184. Morrow, P.E., L.J. Leach, F.A. Smith, R.M. Gelein, J.B. Scott, H.D. Beiter, F.J. Amato, J.J. Picano, C.L. Yuile, T.G. Consler. 1982. Metabolic Fate and Evaluation of Injury in Rats and Dogs Following Exposure to the Hydrolysis Products of Uranium Hexafluoride: July 1979-October 1981. NUREG/CR-2268. Washington DC: U.S. Nuclear Regulatory Commission. December.
185. Muller, C., L. Ruzicka, J. Bakstein. 1967. The sex ratio in the offspring of uranium miners. Acta Univ. Carol. Med. 13(7):599-603.
186. Nomiyama, K., E.C. Foulkes. 1968. Some effects of uranyl acetate on proximal tubular function in the rabbit kidney. Toxicol. Appl. Pharmacol. 13(1):89-98.
187. Nomiyama, K., A. Yamamoto, C. Sato. 1974. Assay of urinary enzymes in toxic nephropathy. Toxicol. Appl. Pharmacol. 27(3):484-490.
188. NRC (National Research Council). 1980. The Effects on Populations of Exposure to Low Levels of Ionizing Radiation: 1980. Washington, DC: National Academy of Sciences.
189. NRC (National Research Council). 1988. Health Risks of Radon and Other Internally Deposited Alpha-Emitters: BEIR IV. Washington, DC: National Academy Press.
190. NRC (National Research Council). 1990. Health Effects of Exposure to Low Levels of Ionizing Radiation: BEIR V. Washington, DC: National Academy Press.
191. NRC (National Research Council). 1999. Health Effects of Exposure to Radon: BEIR VI. Washington, DC: National Academy Press.
192. NRC (National Research Council). 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: The National Academies Press.
193. O'Gara, R.W., J.M. Brown. 1967. Comparison of the carcinogenic actions of subcutaneous implants of iron and aluminum in rodents. J. Natl. Cancer Inst. 38(6): 947-957.
194. Oppenheimer, B.S., E.T. Oppenheimer, I. Danishefsky, A.P. Stout. 1956. Carcinogenic effect of metals in rodents. Cancer Res. 16(5):439-441.
195. Orcutt, J.A. 1949. The toxicology of compounds of uranium following application to the skin. Pp. 377-414 in Pharmacology and Toxicology of Uranium Compounds, C. Voegtlin, H.C.Hodge, eds. New York: McGraw-Hill.
196. OSAGWI (Office of the Special Assistant to the Deputy Secretary of Defense for Gulf War Illnesses). 1998. Environmental Exposure Report: Depleted Uranium in the Gulf. U.S. Department of Defense, Washington, DC [online]. Available: http:// www.gulflink.osd.mil/du/ [accessed July 6, 2007].
197. OSAGWI (Office of the Special Assistant to the Deputy Secretary of Defense for Gulf War Illnesses). 2000. Environmental Exposure Report: Depleted Uranium in the Gulf (II). U.S. Department of Defense, Washington, DC [online]. Available: http://www.gulflink.osd.mil/du_ii/ [accessed July 6, 2007].
198. Parkhurst, M.A., J.R. Johnson, J. Mishima, J.L. Price. 1995. Evaluation of Depleted Uranium Aerosol Data: Its Adequacy for Inhalation Modeling. Report PNL-10903. Richland, WA: Battelle Pacific Northwest Laboratory.
199. Parkhurst, M.A., E.G. Daxon, G.M. Lodde, F. Szrom, R.A. Guilmette, L.E. Roszell, G.A. Falo, C.B. McKee. 2005. Depleted Uranium Aerosol Doses and Risks: Summary of U.S. Assessments (Capstone Summary Report). Columbus, Ohio: Battelle Press.
200. Parkhurst, M.A., F. Szrom, R.A. Guilmette, T.D. Holmes, Y.S. Cheng, J.L. Kenoyer, J.W. Collins, T.E. Sanderson, R.W. Fliszar, K. Gold, J.C. Beckman, J.A. Long. 2004. Capstone Depleted Uranium Aerosols: Generation and Characterization, Vol. 1, Main Text. Attachment 1 of Depleted Uranium Aerosol Doses and Risks: Summary of U.S. Assessments (Capstone Summary Report). PNNL-14168. Prepared for the U.S. Department of the Army, by Pacific Northwest National Laboratory operated by Battelle for the U. S. Department of Energy. October 2004 [online]. Available: http://fhp.osd.mil/du/du_capstone/index.pdf [accessed July 9, 2007].
201. Parkhurst, M.A., F. Szrom, R.A. Guilmette, T.D. Holmes, Y.S. Cheng, J.L. Kenoyer, J.W. Collins, T.E. Sanderson, R.W. Fliszar, K. Gold, J.C. Beckman, J.A. Long. 2004. Capstone Depleted Uranium Aerosols: Generation and Characterization, Vol. 2, Appendices. Attachment 2 of Depleted Uranium Aerosol Doses and Risks: Summary of U.S. Assessments (Capstone Summary Report). PNNL-14168. Prepared for the U.S. Department of the Army, by Pacific Northwest National Laboratory operated by Battelle for the U. S. Department of Energy. October 2004 [online]. Available: http://fhp.osd.mil/du/du_capstone/index.pdf [accessed July 9, 2007].
202. Paternain, J.L., J.L. Domingo, A. Ortega, J.M. Llobet. 1989. The effects of uranium on reproduction, gestation, postnatal survival in mice. Ecotoxicol. Environ. Saf. 17(3):291-296.
203. Pavlakis, N., C.A. Pollock, G. McLean, R. Bartrop. 1996. Deliberate overdose of uranium: Toxicity and treatment. Nephron 72(2):313-317.
204. Pellmar, T.C., A.F. Fuciarelli, J.W. Ejnik, M. Hamilton, J. Hogan, S. Strocko, C. Emond, H.M. Mottaz, M.R. Landauer. 1999. Distribution of uranium in rats implanted with depleted uranium pellets. Toxicol. Sci. 49(1):29-39.
205. Pellmar, T.C., D.O. Keyser, C. Emery, J.B. Hogan. 1999. Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments. Neurotoxicology 20(5):785-792.
206. Periyakaruppan, A., F. Kumar, S. Sarkar, C.S. Sharma, G.T. Ramesh. 2007. Uranium induces oxidative stress in lung epithelial cells. Arch. Toxicol. 81(6):389-395.
207. Petitot, F., A.M. Moreels, F. Paquet. 2004. In vitro evaluation of percutaneous diffusion of uranyl nitrate through intact or excoriated skin of rat and pig. Can. J. Physiol. Pharmacol. 82(2):133-139.
208. Pinkerton, L.E., T.F. Bloom, M.J. Hein, E.M. Ward. 2004. Mortality among a cohort of uranium mill workers: An update. Occup. Environ. Med. 61(1):57-64.
209. Polednak, A.P., E.L. Frome. 1981. Mortality among men employed between 1943 and 1947 at a uranium-processing plant. J. Occup. Med. 23(3):169-178.
210. Popp, W., U. Plappert, W.U. Muller, B. Rehn, J. Schneider, A. Braun, P.C. Bauer, C. Vahrenholz, P. Presek, A. Brauksiepe, G. Enderle, T. Wüst, J. Bruch, T.M. Fliedner, N. Konietzko, C. Streffer, H.J. Woitowitz, K. Norpoth. 2000. Biomarkers of genetic damage and inflammation in blood and bronchoalveolar lavage fluid among former German uranium miners: A pilot study. Radiat. Environ. Biophys. 39(4):275-282.
211. Priest, N.D., G.R. Howells, D. Green, J.W. Haines. 1982. Uranium in bone: Metabolic and autoradiographic studies in the rat. Hum. Toxicol. 1(2):97-114.
212. Purjesz, B., M. Dancz, K. Horvath. 1930. The role of the plexus chorioideus in the secretion of cerebrospinal fluid. Monatsschr. Psychiatr. Neurol. 77:319-347 (as cited in IOM 2000).
213. Ries, L.A.G., M.P. Eisner, C.L. Kosary, B.F. Hankey, B.A. Miller, L. Clegg, A. Mariotto, M.P. Fay, E.J. Feuer, B.K. Edwards, eds. 2003. SEER Cancer Statistics Review, 1975-2000. National Cancer Institute, Bethesda, MD [online]. Available: http://seer.cancer.gov/csr/1975_2000/ [accessed July 16, 2007].
214. Richardson, D.B., S. Wing. 2006. Lung cancer mortality among workers at a nuclear materials fabrication plant. Am. J. Ind. Med. 49(2):102-111.
215. Ritz, B. 1999. Radiation exposure and cancer mortality in uranium processing workers. Epidemiology 10(5):531-538.
216. Ritz, B., H. Morgenstern, D. Crawford-Brown, B. Young. 2000. The effects of internal radiation exposure on cancer mortality in nuclear workers at Rocketdyne/ Atomics International. Environ. Health Perspect. 108(8):743-751.
217. Roberts, E. 1949. Uranyl nitrate. Pp. 561-588 in Pharmacology and Toxicology of Uranium Compounds, C. Voegtlin, H.C. Hodge, eds. New York: McGraw-Hill.
218. Rothstein A. 1949. Uranium trioxide. Pp. 635-647 in Pharmacology and Toxicology of Uranium Compounds, C. Voegtlin, H.C. Hodge, eds. New York: McGraw-Hill.
219. Russell, J.J., R.L. Kathren. 2004. Uranium deposition and retention in a USTUR whole body case. Health Phys. 86(3):273-284.
220. Russell, J.J., R.L. Kathren, S.E. Dietert. 1996. A histological kidney study of uranium and non-uranium workers. Health Phys. 70(4):466-472.
221. Schieferdecker, H., H. Dilger, H. Doerfel, W. Rudolph, R. Anton. 1985. Inhalation of uranium aerosols from uranium dioxide fuel element fabrication. Health Phys. 48(1):29-48.
222. Sehmel, G.A. 1984. Deposition and resuspension. Pp. 533-583 in Atmospheric Science and Power Production, D.A. Randerson, ed. DOE/TIC-27601. Washington, DC: U.S. Department of Energy, Office of Scientific and Technical Information.
223. Sikov, M.R., D.D. Mahlum. 1968. Cross-placental transfer of selected actinides in the rat. Health Phys. 14(3):205-208.
224. Singh, N.P., D.D. Bennett, M.E. Wrenn, G. Saccomanno. 1987. Concentrations of alpha-emitting isotopes of U and Th in uranium miners' and millers' tissues. Health Phys. 53(3):261-265.
225. Spiegl, C.J. 1949. Uranium hexafluoride. Pp. 532-548 in Pharmacology and Toxicology of Uranium Compounds, C. Voegtlin, H.C. Hodge, eds. New York: McGraw-Hill.
226. Squibb, K.S., R.W. Leggett, M.A. McDiarmid. 2005. Prediction of renal concentrations of depleted uranium and radiation dose in Gulf War veterans with embedded shrapnel. Health Phys. 89(3):267-273.
227. Stayner, L.T., T. Meinhardt, R. Lemen, D. Bayliss, R. Herrick, G.R. Reeve, A.B. Smith, W. Halperin. 1985. A retrospective cohort mortality study of a phosphate fertilizer production facility. Arch. Environ. Health 40(3):133-138.
228. Stearns, D.M., M. Yazzie, A.S. Bradley, V.H. Coryell, J.T. Shelley, A. Ashby, C.S. Asplund and R.C. Lantz. 2005. Uranyl acetate induces hprt mutations and uranium-DNA adducts in Chinese hamster ovary EM9 cells. Mutagenesis 20(6):417-423.
229. Stevens, W., F.W. Bruenger, D.R. Atherton, J.M. Smith, G.N. Taylor. 1980. The distribution and retention of hexavalent 233U in the beagle. Radiat. Res. 83(1): 109-126.
230. Stokinger, H.E., R.C. Baxter, H.P. Dygent et al. 1953. Toxicity following inhalation for 1 and 2 years. Pp. 1371-1776 in Pharmacology and Toxicology of Uranium Compounds, C. Voegtlin, H.C. Hodge, eds. New York: McGraw-Hill.
231. Sutter, S.L., J.W. Johnson, J.A. Glissmeyer, G.A. Athey. 1985. BTD Building Uranium Mass Balance Study. Report PNL-5344. Richland, WA: Pacific Northwest Laboratory.
232. Szrom, F., E.G. Daxon, M.A. Parkhurst, G.A. Falo, J.W. Collins. 2004. Level II and Level III Inhalation and Ingestion Dose Methodology: Calculations and Results. Attachment 4 of Depleted Uranium Aerosol Doses and Risks: Summary of U.S. Assessments. PNWD-3480. Prepared for the U.S. Army by Battelle. October 2004 [online]. Available: http://fhp.osd.mil/du/du_capstone/index.pdf [accessed July 9, 2007].
233. Tasat, D.R., B.M. de Rey. 1987. Cytotoxic effect of uranium dioxide on rat alveolar macrophages. Environ Res. 44(1):71-81.
234. Teta, M.J., M. Ott. 1988. A mortality study of a research, engineering, metal fabrication facility in western New York State. Am. J. Epidemiol. 127(3):540-551.
235. The Royal Society. 2001. The Health Hazards of Depleted Uranium Munitions, Part I. Policy Document 6/01. The Royal Society, London. May 22, 2001[online]. Available: http://www.royalsoc.ac.uk/document.asp?tip=1&id=1431 [accessed July 12, 2007].
236. The Royal Society. 2002. The Health Hazards of Depleted Uranium Munitions, Part II Policy Document 5/02. The Royal Society, London [online]. Available: www.royalsociety.ac.uk [accessed July 10, 2007].
237. Thun, M., L. Stayner, D. Brown, R. Waxweiler. 1982. Mining and deaths from chronic renal failure. Lancet 2(8298):606.
238. Thun, M.J., D.B. Baker, K. Steenland, A.B. Smith, W. Halperin, T. Berl. 1985. Renal toxicity in uranium mill workers. Scand. J. Work Environ. Health 11(2):83-90.
239. Tymen, H., P. Gerasimo, D. Hoffschir. 2000. Contamination and decontamination of rat and human skin with plutonium and uranium, studied with a Franz's chamber. Int. J. Radiat. Biol. 76(10):1417-1424.
240. Ubios, A.M., M.B. Guglielmotti, T. Steimetz, R.L. Cabrini. 1991. Uranium inhibits bone formation in physiologic alveolar bone modeling and remodeling. Environ. Res. 54(1):17-23.
241. Ubios, A.M., M.J. Piloni, M. Marzorati, R.L. Cabrini. 1994. Bone growth is impaired by uranium intoxication. Acta Odontol. Latinoam. 8(2):3-8.
242. Ubios, A.M., M. Marzorati, R.L. Cabrini. 1997. Skin alterations induced by longterm exposure to uranium and their effect on permeability. Health Phys. 72(5):713-715.
243. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). 2000. Sources and Effects of Ionizing Radiation, Vol. 1. Sources. New York: United Nations.
244. USACHPPM (U.S. Army Center for Health Promotion and Preventive Medicine). 2000. Depleted Uranium-Human Exposure Assessment and Health Risk Characterization in Support of the Environmental Exposure Report "Depleted Uranium in the Gulf" of the Office of the Special Assistant to the Secretary of Defense for Gulf War Illnesses, Medical Readiness and Military Deployments (OSAGWI), OSAGWI Levels I, II and III Scenarios. Health Risk Assessment Consultation No. 26-MF-7555-00D. Aberdeen Proving Ground, Maryland. September 15, 2000 [online]. Available: http://www.gulflink.osd.mil/chppm_du_rpt_index.html [accessed July 16, 2007].
245. USAF (U.S. Air Force). 2003. Operation Iraqi Freedom - by the Numbers. Assessment and Analysis Division, U.S. Air Force. April 30, 2003 [online]. Available: http://www.globalsecurity.org/military/library/report/2003/uscentaf_oif_report_30 apr2003.pdf [accessed July 9, 2007].
246. Vich, Z., J. Kriklava. 1970. Erythrocytes of uranium miners: The red blood picture. Br. J. Ind. Med. 27(1):83-85.
247. Voegtlin, C., H.C. Hodge, eds. 1949. Pharmacology and Toxicology of Uranium Compounds, Vols 1 and 2. New York: McGraw-Hill.
248. Voegtlin, C., H.C. Hodge, eds. 1953. Pharmacology and Toxicology of Uranium Compounds, Vols 3 and 4. New York: McGraw-Hill.
249. Wan, B., J.T. Fleming, T.W. Schultz, G.S. Sayler. 2006. In vitro immune toxicity of depleted uranium: Effects on murine macrophages, CD 4+ T cells, gene expression profiles. Environ. Health Perspect. 114(1):85-91.
250. Waxweiler, R., V.E. Archer, R.J. Roscoe, A. Watanabe, M. Thun. 1983. Mortality patterns among a retrospective cohort of uranium mill workers. Pp. 428-435 in Epidemiology Applied to Health Physics: Proceedings of the 16th Midyear Topical Meeting of the Health Physics Society, Jan. 9-13, 1983, Albuquerque, NM. Report DE83014383/CONF-830101. Springfield, VA: National Technical Information Service, U.S. Department of Commerce.
251. Wechsler, D. 1981. Manual for the WAIS-R. New York: Psychological Corporation.
252. Wedeen, R.P., I. Udasin, N. Fiedler, P. D'Haese, M.E. Debroe, E. Gelpi, K.W. Jones. 1998. Patterns and tubular proteinuria from metals and solvents. Pp. 311-321 in Biomarkers: Medical and Workplace Applications, M.L. Mendelsohn, L.C. Mohr, J.P. Peeters, eds. Washington, DC: Joseph Henry Press.
253. WHO (World Health Organization). 1987. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction, 2nd Ed. Cambridge: Cambridge University Press.
254. WHO (World Health Organization). 2001. Depleted Uranium: Sources, Exposure and Health Effects. WHO/SDE/PHE/01.1. World Health Organization, Geneva. April 2001 [online]. Available: http://www.who.int/ionizing_radiation/pub_meet/ir_ pubs/en/index.html [accessed July 11, 2007].
255. Wise, S.S., W.D. Thompson, A.M. Aboueissa, M.D. Mason, J.P. Wise. 2007. Particulate depleted uranium is cytotoxic and clastogenic to human lung cells. Chem. Res. Toxicol. 20(5):815-820.
256. Wrenn, M.E., P.W. Durbin, B. Howard, J.L. Lipsztein, J. Rundo, E.T. Still, D.L. Willis. 1985. Metabolism of ingested uranium and radium. Health Phys. 48(5):601-633.
257. Wrenn, M.E., N.P. Singh, A.S. Paschoa, R.D. Lloyd, G. Saccomanno. 1985. Concentrations of Uranium and Thorium Isotopes in Uranium Millers' and Miners' Tissues. NUREG/CR-4382. Washington: U.S. Nuclear Regulatory Commission.
258. Wrenn, M.E., N.P. Singh, H. Ruth, M.L. Rallison, D.P. Burleigh. 1989. Gastrointestinal absorption of soluble uranium from drinking water by man. Radiat. Prot. Dosim. 26(1):119-122.
259. Wrenn, M.E., J.L. Lipsztein, L. Bertelli. 1989. Pharmokinetic models relevant to toxicity and metabolism for uranium in humans and animals. Radiat. Prot. Dosim. 26(1):243-248.
260. Wu, J.M., J.X. Fan. 1982. Management of a case of acute uranium poisoning and renal failure after extensive burns by uranyl nitrate [in Chinese]. Zhonghua Yi Xue Za Zhi. 62(9):516-518.
261. Yazzie, M., S.L. Gamble, E.R. Civitello, D.M. Stearns. 2003. Uranyl acetate causes DNA single strand breaks in vitro in the presence of ascorbate (vitamin C). Chem. Res. Toxicol. 16(4):524-530.
262. Zaire, R., M. Notter, W. Riedel, E. Thiel. 1997. Unexpected rates of chromosomal instabilities and alterations of hormone levels in Namibian miners. Radiat. Res. 147(5):579-584.
263. Zamora, M.L., B.L. Tracy, J.M. Zielinski, D.P. Meyerhof, M.A. Moss. 1998. Chronic ingestion of uranium in drinking water: A study of kidney bioeffects in humans. Toxicol. Sci. 43(1):68-77.
264. Zamora, M.L., J.M. Zielinski, D.P. Meyerhof, B.L. Tracy. 2002. Gastrointestinal absorption of uranium in humans. Health Phys. 83(1):35-45.
265. Zhao, S.L., F.Y. Zhao. 1990. Nephrotoxic limit and annual limit on intake for natural U. Health Phys. 59(5):619-623.